Clinton Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,891
| Closed | -$322K | – | 512 |
|
|
2018
Q1 | $322K | Buy |
+2,891
| New | +$322K | 0.03% | 302 |
|
|
2017
Q4 | – | Sell |
-1,812
| Closed | -$254K | – | 538 |
|
|
2017
Q3 | $254K | Buy |
+1,812
| New | +$254K | 0.03% | 339 |
|
|
2016
Q4 | – | Sell |
-10,818
| Closed | -$1.33M | – | 1066 |
|
|
2016
Q3 | $1.33M | Sell |
10,818
-50,861
| -82% | -$6.23M | 0.06% | 388 |
|
|
2016
Q2 | $7.2M | Buy |
+61,679
| New | +$7.2M | 0.32% | 84 |
|
|
2015
Q2 | – | Sell |
-9,459
| Closed | -$1.64M | – | 738 |
|
|
2015
Q1 | $1.64M | Buy |
+9,459
| New | +$1.64M | 0.43% | 57 |
|
|
2014
Q3 | – | Sell |
-8,977
| Closed | -$1.4M | – | 507 |
|
|
2014
Q2 | $1.4M | Buy |
8,977
+5,072
| +130% | +$793K | 0.7% | 24 |
|
|
2014
Q1 | $594K | Buy |
+3,905
| New | +$594K | 0.22% | 141 |
|